Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed bis-carbonylation route offers high yields and substrate tolerance for scalable pharmaceutical intermediate manufacturing.
Patent CN108484499B reveals a green rhodium-catalyzed route for isoquinoline synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110467640B reveals a novel Mn-promoted synthesis for phosphorus-containing heterocycles, offering cost reduction in API manufacturing and scalable production.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.
Patent CN113735778B reveals efficient Ag2O promoted route. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing globally.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN109851599B details a novel one-pot synthesis of 2-aminobenzofurans using TIPS-EBX. This method offers high yields and simplified purification for pharmaceutical intermediates.
Patent CN101407459B details a novel synthesis of monohydroxy-2-acylphenylacetates. This route offers scalable production for antitumor drug leads with optimized cost efficiency.
Patent CN115772157B reveals cobalt-catalyzed synthesis enabling cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN114920707B reveals a novel iodine-promoted synthesis using DMF as a carbon source. This method offers significant cost reduction in API manufacturing and simplified supply chains for pharmaceutical intermediates.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Novel iodine-promoted cyclization using DMF as carbon source. Streamlines API intermediate manufacturing with high efficiency and operational simplicity.
Patent CN113880781A reveals a novel glucose-derived route for 3-trifluoromethyl-1,2,4-triazoles, offering sustainable cost reduction and scalable API intermediate manufacturing.
Novel Pd-catalyzed route for trifluoroacetyl indoline. Reduces cost and improves scalability for pharmaceutical intermediates.
Patent CN114539044B enables high-yield Anhydroicaritin production. Novel route ensures purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN110467579B reveals a metal-free, iodine-promoted route for 5-trifluoromethyl-1,2,4-triazoles. Discover cost-effective API intermediate manufacturing solutions.
Patent CN113735778A reveals a silver-promoted cyclization route for high-purity imidazoles, offering cost-effective scalable manufacturing solutions.
Patent CN119060008A reveals novel palladium-catalyzed pathway for benzopyran thioesters. Offers significant supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104140430B enables recycling of S-isomers via halogenation. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering safer CO surrogates and improved supply chain reliability for API manufacturing.